The Bull Market Report Updates Outlooks on Starbucks, Procter & Gamble, Coventry Health Care, and Aetna
Posted on: Friday, 5 May 2006, 12:02 CDT
PRINCETON, N.J., May 5 /PRNewswire/ -- The Bull Market Report (http://www.bullmarket.com/), an online investment newsletter focused on long- term growth and income-generating stocks, announced today that it has provided subscribers with earnings reviews for Starbucks , Procter & Gamble , Coventry Health Care , and Aetna .
All paid and trial subscribers to The Bull Market Report can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/index.php?refer=BMR116P
In its report, The Bull Market Report wrote: "Nonetheless, a 5% same-store sales pace combined with many years of rapid store growth makes for a still- potent growth story [at Starbucks]. Keep in mind that it expects 20-25% profit growth over the next 3-5 years. If it simply maintains but doesn't accelerate the pace of store opening, Starbucks will have at least 5 years of double- digit store growth."
The Bull Market Report looked at the following topics, among others: -- Is Starbucks still worth owning considering the stock's high valuation? -- How will Wal-Mart's inventory reduction efforts affect Procter & Gamble? -- Has the sell-off in the health insurance sector been overdone? About The Bull Market Report:
Launched in 1997, The Bull Market Report has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The Bull Market Report's Recommended List includes over 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. The Bull Market Report is one of the oldest continuously published investment newsletters online, and its Recommended List has consistently outperformed the major market indices.
NOTE: This release was published by Indie Research Advisors, LLC (CRD #131926), a registered investment advisor with the NASD and State of NJ. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
CONTACT: Marcie Martin, +1-888-278-5515
Indie Research Advisors, LLC
CONTACT: Marcie Martin of Indie Research Advisors, +1-888-278-5515
Web site: http://www.bullmarket.com/
Source: PRNewswire
Related Articles
- The Bank of New York Mellon's Pershing Unit Expands Separately Managed Account Solutions for Independent Registered Investment Advisors and Advisors in Transition
- Securian Retirement Helps Advisors With Registered Investment Advisor Platforms
- Automatic Features Are Driving 401(K) Plan Participation at U.S. Companies, Reveals Diversified Investment Advisors, Inc. Survey
- The 'Biofuels Market Outlook: Market Drivers, Growth Opportunities and Regulatory Change' is a New Report That Provides Forecasts for the Biodiesel and Ethanol Markets
- Pacific Growth Equities Initiates Research Coverage of U.S. Geothermal Inc.
- AstraZeneca Makes $100M Research Investment In Boston
- Misonix to Present at the Sanders Morris Harris Middle Market Investor Growth Conference
- California Pizza Kitchen to Present at the CIBC World Markets Consumer Growth Conference on July 12, 2006; Release of Preliminary Results for the Second Quarter Scheduled for July 11, 2006
- Diversified Investment Advisors Sponsors the Institute for Diversity in Health Management
- Green Hills Software Leads in Real-Time Operating System Market Share Growth for Fourth Straight Year
 |
 |
User Comments (0)
RSS Feeds